Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Rev. AMRIGS ; 60(1): 32-37, jan.-mar.2016. tab, ilus
Article in Portuguese | LILACS | ID: biblio-831221

ABSTRACT

Introdução: os cânceres de pele são reconhecidamente relacionados à exposição solar que, associada à suscetibilidade individual à radiação ultravioleta, constitui o fator de risco mais importante para o desenvolvimento da doença. Objetivos: relacionar o uso de protetor solar diário ou eventual com conhecimento da relação causal entre o sol e o câncer de pele, tal como a presença ou ausência de lesão de pele suspeita de neoplasia maligna em relação ao conhecimento sobre a relação supracitada. Métodos: um estudo analítico transversal foi realizado através da aplicação de 107 questionários aos participantes da Campanha de Prevenção ao câncer de pele realizada em Morro Redondo-RS. Resultados: uso diário de fotoprotetor foi mais frequente entre as mulheres (21,49%) e a prevalência de lesão suspeita de malignidade nesse grupo foi nula, enquanto que 20,55% dos homens referiram nunca se proteger, e dentre eles o predomínio de lesões suspeitas foi de 7,47%. Observouse que 67% dos entrevistados que tem conhecimento da exposição solar como fator de risco para câncer de pele usam fotoprotetor e, entre os que desconhecem a relação, 56% nunca se protegem. Foi demonstrado que 17% dos que conhecem tal relação tiveram lesão de pele suspeita e, entre os que desconhecem, apenas 1% obteve o mesmo diagnóstico. Conclusão: o uso de fotoprotetor mostrou-se indispensável para prevenção de lesão de pele e este deve ser orientado corretamente. Portanto, campanhas de prevenção ao câncer de pele são importantes para a conscientização da população sobre proteção solar, devendo ser estimuladas.


Introduction: Skin cancers are known to be related to sun exposure, which, associated with individual susceptibility to ultraviolet radiation, is the major risk factor for developing the disease. Aims: To relate the daily or occasional use of sunscreen with awareness of the causal relationship between sun and skin cancer, such as the presence or absence of skin lesions suspected of malignancy in relation to the knowledge of the above-mentioned relationship. Methods: A cross-sectional analytical study was carried out by administering 107 questionnaires to participants of the Skin Cancer Prevention Campaign held in Morro Redondo, RS. Results: Daily use of sunscreen was more frequent among women (21.49%) and the prevalence of suspected malignant lesions in this group was zero, while 20.55% of men reported they never used it, and among them the predominance of suspicious lesions was 7.47%. It was found that 67% of respondents who are aware of sun exposure as a risk factor for skin cancer use sunscreen, and among those who are unaware of the relationship, 56% never protect themselves. It has been shown that 17% of those who are aware of this relationship did have a suspicious skin lesion, and among those who are unaware only 1% got the same diagnosis. Conclusion: Sunscreen use was shown to be essential for preventing skin damage and must be correctly oriented. Therefore, skin cancer prevention campaigns are important for raising public awareness about sun protection and should be encouraged.


Subject(s)
Humans , Male , Female , Skin Neoplasms/prevention & control , Health Promotion
2.
An. bras. dermatol ; 90(1): 117-119, Jan-Feb/2015. graf
Article in English | LILACS | ID: lil-735728

ABSTRACT

Skin infections by Mycobacterium marinum are quite rare in our environment and, therefore, little studied. The majority of the lesions appear three weeks after traumas in aquariums, beaches and fish tanks. Lymph node drainage and systematization of the disease are rare and most lesions disappear in about three years. This case aims to show the effectiveness of the treatment used (lymecycline 150 mg/orally/day). This medication may be a new therapeutic option for the treatment of Mycobacterium marinum.


Subject(s)
Adolescent , Female , Humans , Anti-Bacterial Agents/therapeutic use , Lymecycline/therapeutic use , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium marinum/drug effects , Skin Diseases, Bacterial/drug therapy , Biopsy , Mycobacterium Infections, Nontuberculous/pathology , Skin Diseases, Bacterial/pathology , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL